Stipend and Dates

Up to $8,300. (Multiple payments)

Note: You cannot pick which cohort you go into. The 1st cohort is filled before patients are placed in the next cohort. You must be able to do any of the cohorts. Cohort 5B
   
Day -17 - This is the LAST day to screen childbearing females or females with tubal ligations. These females CANNOT screen after this date. Sep 18 (Can no longer screen for this cohort)
Only males and Non-childbearing women can screen after Sep18. (PMP, hysterectomy, salpingectomy or oophorectomy)  
   
Day -2 Admit Oct 04, 2022 Tue
*Holter monitoring starts Day -1 to Day 5 (No electronics = cell phones, computers, TV, etc.)  
Day 5 Discharge (a payment within 10 business days after this day is completed) Oct 10, 2022 Mon
Day 7 Outpatient Visit Oct 12
Day 10 Outpatient Visit Oct 15
Day 15 Outpatient Visit Oct 20
Day 22 Final Outpatient Visit (a payment within 10 business days after this day is completed) Oct 27, 2022 Thurs

 

Click here to make an appointment for NO 0009-0625 Part A

Or call 210-225-5437 for more information

Study Criteria

Healthy non-smoking overweight Males and Females

Age:  18-55

BMI: 25.0 to 34.9 kg/m2

 

Study Information

Indication: The investigational drug is being developed as a potential treatment for overweight and / obesity.

Route of Administration: Oral

Washout from previous study: Participation in any clinical study within 30 days before receiving study drug in this study.

Acceptable Birth Control for Females (if Childbearing):  Females of child bearing potential must agree to use a highly effective method of contraception during the study treatment period and until 19 days after the end of the study. Highly effective methods of contraception are listed below:

  • Intrauterine device with male condoms
  • Intrauterine system with male condoms
  • Partner has had a Vasectomy (confirmed by the absence of sperm)
  • Stable Hormonal contraception with approved oral, intravaginal, transdermal, injectable or implantable (and male condoms).
  • Bilateral tubal occlusion/ligation
  • Sexual Abstinence

Females in the following categories are considered non-childbearing:

  • Documented total hysterectomy (removal of uterus), bilateral salpingectomy (removal of both Fallopian tubes), or bilateral oophorectomy (removal of both ovaries)
  • Menopause more than 12 months prior to study entry (stopped having monthly menstrual periods more than 12 months ago).
  • Greater than or equal to 60 years of age

The male participant should use a condom during study treatment and until the end of study.

 

Study Reminders

  • 8 hours fasting is required for lab work (only water is allowed)
  • If taking medications, bring them to your screening appointment (including prescription, over the counter, herbal supplements and vitamins)
  • Bring a valid, non-expired photo ID with you when you attend your screening visit.  We accept a valid government issued identification card such as a driver's license, state issued ID card or passport.  You will be required to show this same photo ID at all study visits
  • Arrive 30 minutes before your appointment to complete paper work.
Reference
NO 0009-0625 Part A
Name
Healthy Overweight Males and Females
Details
Not Currently Screening. Pending lab results. Last cohort.
Gender
Male or Female
Payment amount
Up to $8,300
Age
18 - 55
Smoking
Non-smokers